Indian pharma company buys Natrol

HYDERABAD, India — Aurobindo Pharma Limited last week announced the completion of its acquisition of supplement maker Natrol through its wholly owned subsidiary Aurobindo Pharma USA for $132.5 million. APUSA emerged as the highest and best bidder to acquire assets of Natrol under the auction process by the United States Bankruptcy Court for the District of Delaware.

 

APUSA expects the profitability of the company to improve by combining the strength of both enterprises in creating a fully integrated nutraceuticals platform in the United States and other international markets.

 

“I am pleased that Aurobindo recognizes the values of Natrol’s uncompromised quality products, loyal customers, talented employees and solid relationships with our retailer partners," stated Mesrop Khoudagoulian, Natrol CEO. "We look forward to working with the Aurobindo team to further expand our over-the-counter product portfolio and our reach with the financial support of strong owners.”

 

“Natrol comes with certain well-established brands and an extensive distribution network consisting of retail pharmacy chains and specialty health food stores, to help us tactically position ourselves in the U.S. nutraceuticals space and offer an effective growth strategy to expand market penetration going forward," commented Narayanan Govindarajan, managing director of Aurobindo.